Share Price | Cryo-Cell International, Inc. Stock Analysis & Recommendation

Q: How big is Cryo-Cell International, Inc.?

Market Cap: As of Jun 18, Cryo-Cell International, Inc. has a market capitalization of 70.88 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 32.10 million, while the sum of Net Profit is 0.13 million.Balance Sheet Snapshot: As of Nov'24, the Shareholder's Funds are reported at -13.22 million, and the Total Assets amount to 64.68 million.

Q: What does Cryo-Cell International, Inc. do?

Overview: Cryo-Cell International, Inc. operates in the transport services industry and is classified as a micro-cap company.Financial Snapshot: Most recent Net Sales: 8 Million (Quarterly Results - Feb 2025) Most recent Net Profit: 0 Million (Quarterly Results - Feb 2025) Market-cap: USD 70.88 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.68 Return on Equity: 2.12% Price to Book: -4.84Contact Details: Registrar Address: Not available.

Q: Is Cryo-Cell International, Inc. overvalued or undervalued?

As of 18 October 2022, the valuation grade for Cryo-Cell International, Inc. moved from fair to risky, indicating a significant downgrade in its financial outlook. The company appears to be overvalued based on its current metrics, particularly given its negative P/E ratio and price-to-book value of -5.02. Additionally, the EV to EBITDA ratio stands at 15.97, which is notably high compared to its peers.In comparison to similar companies, Cryo-Cell's valuation is starkly unfavorable; for instance, Bristow Group, Inc. has a P/E of 9.07 and an EV to EBITDA of 7.42, showcasing a more attractive investment profile. Other peers, such as Seacor Marine Holdings, Inc. and ModivCare, Inc., also reflect risky valuations but with less severe metrics than Cryo-Cell. Given these factors, the company is assessed as overvalued, particularly in light of its poor stock performance relative to the S&P 500, where it has underperformed significantly over the past year and beyond.

Q: Is Cryo-Cell International, Inc. technically bullish or bearish?

As of 8 September 2025, the technical trend for Cryo-Cell International, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages, bearish readings on both weekly and monthly Bollinger Bands, and a monthly bearish MACD. Additionally, the KST shows a mildly bullish signal on the weekly timeframe but remains bearish monthly, indicating mixed signals across different periods. The stock has underperformed the S&P 500 significantly, with a year-to-date return of -39.27% compared to the S&P 500's 12.22%, and a 3-year return of -40.00% versus 70.41% for the benchmark.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

562

Shareholding (Nov 2025)

FII

0.29%

Held by 2 FIIs

DII

92.23%

Held by 3 DIIs

Promoter

5.09%

How big is Cryo-Cell International, Inc.?

22-Jun-2025

As of Jun 18, Cryo-Cell International, Inc. has a market capitalization of 70.88 million, with recent net sales of 32.10 million and a net profit of 0.13 million over the last four quarters. The company's shareholder's funds are -13.22 million, and total assets are 64.68 million as of Nov'24.

View full answer

What does Cryo-Cell International, Inc. do?

22-Jun-2025

Cryo-Cell International, Inc. is a micro-cap company in the transport services industry, with recent net sales of $8 million and a market cap of $70.88 million. It is currently loss-making, with a P/E ratio of NA and a dividend yield of 0.00%.

View full answer

Is Cryo-Cell International, Inc. overvalued or undervalued?

25-Jun-2025

As of October 18, 2022, Cryo-Cell International, Inc. is considered overvalued and has a risky financial outlook due to its negative P/E ratio, high EV to EBITDA ratio, and poor stock performance compared to peers and the S&P 500.

View full answer

Is Cryo-Cell International, Inc. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Cryo-Cell International, Inc. is in a bearish trend, indicated by negative signals from moving averages and Bollinger Bands, despite a mildly bullish weekly KST, and has significantly underperformed the S&P 500 with a year-to-date return of -39.27%.

View full answer

Compare Cryo-Cell International, Inc. with Similar Stocks

Green Plains Partners LP Seacor Marine Holdings, Inc.ModivCare, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Transport Services

Market cap

USD 41 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.59

Return on Equity

0.81%

Price to Book

-2.76

Revenue and Profits:

Net Sales:

8 Million

(Quarterly Results - Nov 2025)

Net Profit:

-4 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-13.91%

6 Months

-39.63%

1 Year

-53.38%

2 Years

-53.67%

3 Years

-2.94%

4 Years

-62.41%

5 Years

-67.0%

Cryo-Cell International, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.11%

EBIT Growth (5y)

-8.95%

EBIT to Interest (avg)

1.97

Debt to EBITDA (avg)

3.02

Net Debt to Equity (avg)

-0.71

Sales to Capital Employed (avg)

-6.23

Tax Ratio

100.00%

Dividend Payout Ratio

510.20%

Pledged Shares

Institutional Holding

13.51%

ROCE (avg)

60.29%

ROE (avg)

36.59%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-2.76

EV to EBIT

11.49

EV to EBITDA

8.71

EV to Capital Employed

-8.24

EV to Sales

1.57

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Nov 2025

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 4 Schemes (2.4%)

Foreign Institutions

Held by 2 Foreign Institutions (0.29%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is 0.00% vs -1.27% in Aug 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is -642.86% vs 75.00% in Aug 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Aug'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.80",
          "val2": "7.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.60",
          "val2": "2.30",
          "chgp": "-256.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.50",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.80",
          "val2": "0.70",
          "chgp": "-642.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-505.80%",
          "val2": "242.90%",
          "chgp": "-74.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Nov'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Nov 2025 is -1.25% vs 2.24% in Nov 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Nov 2025 is -700.00% vs 104.21% in Nov 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.60",
          "val2": "32.00",
          "chgp": "-1.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.90",
          "val2": "4.80",
          "chgp": "-60.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.10",
          "val2": "1.90",
          "chgp": "10.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "0.90",
          "chgp": "-188.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.40",
          "val2": "0.40",
          "chgp": "-700.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.30%",
          "val2": "118.50%",
          "chgp": "-10.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ

Nov'25

Aug'25

Change(%)

Net Sales

7.80

Operating Profit (PBDIT) excl Other Income

-3.60

2.30

-256.52%

Interest

0.50

Exceptional Items

-0.20

Consolidate Net Profit

-3.80

0.70

-642.86%

Operating Profit Margin (Excl OI)

-505.80%

242.90%

-74.87%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Nov 2025 is 0.00% vs -1.27% in Aug 2025

Consolidated Net Profit

QoQ Growth in quarter ended Nov 2025 is -642.86% vs 75.00% in Aug 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Nov'25

Nov'25

Nov'24

Change(%)

Net Sales

31.60

32.00

-1.25%

Operating Profit (PBDIT) excl Other Income

1.90

4.80

-60.42%

Interest

2.10

1.90

10.53%

Exceptional Items

-0.80

0.90

-188.89%

Consolidate Net Profit

-2.40

0.40

-700.00%

Operating Profit Margin (Excl OI)

15.30%

118.50%

-10.32%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Nov 2025 is -1.25% vs 2.24% in Nov 2024

Consolidated Net Profit

YoY Growth in year ended Nov 2025 is -700.00% vs 104.21% in Nov 2024

All Annual Results

Company CV

About Cryo-Cell International, Inc.

Cryo-Cell International, Inc.

Transport Services

No Details Available.

Company Coordinates

No Company Details Available